Concepedia
Statistics
Publications
9
Citations
886
H-Index
Active since
2011
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)
South Texas Accelerated Research Therapeutics
The Barbara Ann Karmanos Cancer Institute
University of California, San Francisco
Cleveland Clinic
Robert Bachman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and targeted therapy.
Publications per year
2011–2018
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David Hewitt, Sheena K. Aurora, David W. Dodick et al. · Cephalalgia · 2011 · 262 citations
Medicine, Pharmacology, Pharmacotherapy +14
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Tiffini Voss, Richard B. Lipton, David W. Dodick et al. · Cephalalgia · 2016 · 246 citations
Medicine, Pharmacology, Pharmacotherapy +17
Pembrolizumab (pembro) plus chemotherapy as front-line therapy for advanced NSCLC: KEYNOTE-021 cohorts A-C.
Shirish M. Gadgeel, James Stevenson, Corey J. Langer et al. · Journal of Clinical Oncology · 2016 · 85 citations
Medicine, Oncology, Pharmacology +14
Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design
Tony W. Ho, Eric Pearlman, Donald W. Lewis et al. · Cephalalgia · 2012 · 81 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study
Shirish M. Gadgeel, James Stevenson, Corey J. Langer et al. · Lung Cancer · 2018 · 81 citations
Medicine, Oncology, Pharmacology +15
1–5 of 9